Drugdiscovery >> Clinical Trials >> News
4013
Views
Pacritinib to be tested in a late-stage trial as a treatment for myelofibrosis - drugdiscovery.com
Pacritinib to be tested in a late-stage trial as a treatment for myelofibrosis - drugdiscovery.com


Cell Therapeutics announced a late-stage trial of pacritinib as a treatment for a blood disorder called myelofibrosis. Pacritinib will be compared to the best available treatment for myelofibrosis, Jakafi.
Read More >>


Tags: Pacritinib, Cell Therapeutics, myelofibrosis, clinical trial, treatment - October 8, 2013
Related Articles
3843
Views
GSK’s Duchenne muscular dystrophy failed in late-stage trial GSK’s Duchenne muscular dystrophy failed in late-stage trial
A potential treatment for Duchenne muscular dystrophy, drisapersen, did not meet the study's main goal of generating a statistically significant improvement in a six-minute walking distance test comp Read More >>

Tags: Duchenne muscular dystrophy, drisapersen, new treatment, clinical trial

6961
Views
 Melflufen enters Phase II study in the treatment of multiple myeloma patients Melflufen enters Phase II study in the treatment of multiple myeloma patients
Melflufen, also known as J1, will be used in combination with dexamethasone for late stage, relapsing or relapsing/refractory patients with multiple myeloma. The aim of this phase study is to determi Read More >>

Tags: melflufen, J1, multiple myeloma, late stage, clinical trial

2958
Views
BMS diabetes drug successful in late-stage study BMS diabetes drug successful in late-stage study
Bristol-Myers Squibb has announced that its diabetes drug dapagliflozin, helped improve blood sugar levels and reduce body weight in patients with type 2 diabetes who were taking a combination of metf Read More >>

Tags: type 2 diabetes, Bristol-Myers Squibb, dapagliflozin, clinical trial, Forxiga

4215
Views
Psoriasis Drug Tested Against Diabetes Psoriasis Drug Tested Against Diabetes
Encouraging results from the T1DAL study (Targeting effector memory T-cells with alefacept in new onset type 1 diabetes), led by Mark Rigby from Indiana University and Riley Hospital for Children in I Read More >>

Tags: alefacept, diabetes, psoriasis, treatment, clinical trial

4031
Views
'Double Chin' drug successful in two late-stage clinical studies 'Double Chin' drug successful in two late-stage clinical studies
Kythera Biopharmaceuticals’ drug, ATX-101, which is used for reducing fat in the submental area of the neck, reached its main and secondary goals in late stage clinical trials. Read More >>

Tags: Kythera, double chin, new drug, clinical trials, ATX-101

17572
Views
Autologous immune cell therapy tested in liver cancer patients Autologous immune cell therapy tested in liver cancer patients
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of proprietary cell therapies for certain degenerative and malignant diseases, announced positive results from its phase Read More >>

Tags: cancer stem cell, dendritic cell, immunotherapy, liver cancer, phase I trial, liver cancer, hepatocellular carcinoma, HCC, clinical trial, immune cells, therapy, dendritic cells

13679
Views
PAT-SM6 antibody successful in Phase I/IIa clinical trial for multiple myeloma PAT-SM6 antibody successful in Phase I/IIa clinical trial for multiple myeloma
Patrys Limited has released additional clinical data for six end-stage, multi-resistant multiple myeloma patients treated with PAT-SM6. The trial is progressing to its 4th and final patient cohort. Read More >>

Tags: multiple myeloma, clinical trial, PAT-SM6, antibody, Patrys Limited, end stage

20630
Views
Lilly’s experimental lung cancer drug successful in phase III clinical trial Lilly’s experimental lung cancer drug successful in phase III clinical trial
Eli Lilly & Co. announced in a press release that necitumumab (IMC-11F8), in combination with gemcitabine and cisplatin, as first-line treatment for stage IV squamous cell non-small cell lung cancer Read More >>

Tags: Eli Lilly, necitumumab, advanced lung cancer, new drug,experimental drug, stage IV, squamous cell non-small cell lung cancer

5177
Views
Humira as a treatment for hidradenitis suppurativa- the results of Phase 2 trial Humira as a treatment for hidradenitis suppurativa- the results of Phase 2 trial
According to the results of Phase 2 clnical trial, Humira induced a significant response rate, compared to placebo, in adult patients with moderate-to-severe hidradenitis suppurativa (HS). The drug Read More >>

Tags: Humira, AbbVie, hidradenitis suppurativa, clinical trial

4620
Views
Promising treatment for irritable bowel syndrome Promising treatment for irritable bowel syndrome
The drug Eluxadoline showed effective in Phase II clinical trial in the treatment of patients with diarrhea-predominant irritable bowel syndrome ( IBS-D). Phase III trials already started. Read More >>

Tags: Eluxadoline, irritable bowel syndrome, clinical trial, effective treatment

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013